A Review of Neuroprotective Agents

Show simple item record

dc.contributor.author Levi, MS en
dc.contributor.author Brimble, MA en
dc.date.accessioned 2011-09-18T23:29:37Z en
dc.date.issued 2004 en
dc.identifier.citation Current Medicinal Chemistry 11(18):2383-2397 2004 en
dc.identifier.issn 0929-8673 en
dc.identifier.uri http://hdl.handle.net/2292/8018 en
dc.description.abstract The brain remains an area where little corrective surgery can be performed and the reversal of damage is almost impossible. Recently, reports of agents offering neuroprotection have begun to appear in the literature. The concept of neuroprotection is the administration of some agent, which should reverse some of the damage or prevent further damage. Some agents offer protection against cell degeneration to the neuronal cells. Still other agents specifically protect the dopamine neurons and the retina. The majority of neuroprotective agents are antioxidants. An immunosuppressive calcineurin inhibitor, NOS inhibitor, σ- 1 modulator, AMPA antagonist and Ca 2+ channel blocker have all shown neuroprotective activity. An estrogen agonist and two glycoprotein IIb/ IIIa antagonists also exhibit neuroprotective activity.Most of the synthetic compounds presented were not originally designed as neuroprotective agents but were found to possess neuroprotective activity in later studies. Many of these compounds are biologically active natural products, either plant extracts or endogenous peptides/proteins. This review will present the most recent reports on these agents. en
dc.language EN en
dc.relation.ispartofseries Current Medicinal Chemistry en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.sherpa.ac.uk/romeo/issn/0929-8673/ en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.subject antioxidant en
dc.subject neuroprotection en
dc.subject calcineurin en
dc.subject neuroprotective en
dc.subject dopamine en
dc.subject retina en
dc.subject neurodegeneration en
dc.subject stroke en
dc.subject CENTRAL-NERVOUS-SYSTEM en
dc.subject ACTIVATED PROTEIN-C en
dc.subject CEREBRAL-ARTERY OCCLUSION en
dc.subject AMPA RECEPTOR ANTAGONIST en
dc.subject NEONATAL X-IRRADIATION en
dc.subject RAT CORTICAL-NEURONS en
dc.subject MITOCHONDRIAL PERMEABILITY TRANSITION en
dc.subject TRANSIENT FOREBRAIN ISCHEMIA en
dc.subject HUMAN-IMMUNODEFICIENCY-VIRUS en
dc.subject TOLUENE INHALATION EXPOSURE en
dc.title A Review of Neuroprotective Agents en
dc.type Journal Article en
dc.identifier.doi 10.2174/0929867043364522 en
pubs.issue 18 en
pubs.begin-page 2383 en
pubs.volume 11 en
dc.rights.holder Copyright: 2004 Bentham Science Publishers Ltd. en
dc.identifier.pmid 15379704 en
pubs.end-page 2397 en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Review en
pubs.elements-id 39925 en
pubs.org-id Science en
pubs.org-id Chemistry en
pubs.org-id Science Research en
pubs.org-id Maurice Wilkins Centre (2010-2014) en
pubs.record-created-at-source-date 2010-09-01 en
pubs.dimensions-id 15379704 en


Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics